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Germany; and §Faculty of Chemistry, Technical University Dortmund, Dortmund, GermanyABSTRACT The localization and signaling of S-palmitoylated peripheral membrane proteins is sustained by an acylation cycle
in which acyl protein thioesterases (APTs) depalmitoylate mislocalized palmitoylated proteins on endomembranes. However,
the APTs are themselves reversibly S-palmitoylated, which localizes thioesterase activity to the site of the antagonistc palmitoy-
lation activity on the Golgi. Here, we resolve this conundrum by showing that palmitoylation of APTs is labile due to autodepal-
mitoylation, creating two interconverting thioesterase pools: palmitoylated APT on the Golgi and depalmitoylated APT in the
cytoplasm, with distinct functionality. By imaging APT-substrate catalytic intermediates, we show that it is the depalmitoylated
soluble APT pool that depalmitoylates substrates on all membranes in the cell, thereby establishing its function as release factor
of mislocalized palmitoylated proteins in the acylation cycle. The autodepalmitoylating activity on the Golgi constitutes a homeo-
static regulation mechanism of APT levels at the Golgi that ensures robust partitioning of APT substrates between the plasma
membrane and the Golgi.INTRODUCTIONThe acylation cycle is a dynamic reaction-diffusion system
that maintains the spatial organization of palmitoylated
peripheral membrane proteins, which include proto-onco-
gene products of the Ras and Src families as well as signal
transducers of the heterotrimeric G-protein family (1). In
addition to reversible palmitoylation, these proteins typi-
cally also obtain an irreversible lipid modification such as
S-prenylation (2) or N-myristoylation (3). Therefore, the
depalmitoylated forms of these proteins still possess a
weak membrane affinity that allows them to rapidly equili-
brate to all membranes in the cell. This equilibration is facil-
itated by interaction with GDI-like solubilizing factors
(GSFs) (4). S-palmitoylation of membrane-proximal
cysteine residues leads to an increase in the hydrophobicity
and hence the membrane affinity of peripheral membrane
proteins. The cytoplasmic face of the Golgi apparatus is
known to possess S-palmitoyltransferase activity, thus
enriching palmitoylatable peripheral membrane proteins
on this membrane compartment by kinetic trapping (5,6).
Vesicular transport along the secretory pathway directs
this protein enrichment to the plasma membrane (PM),
thereby transferring the nonequilibrium Golgi enrichment
to the PM. Palmitoylated PM-associated proteins may spon-
taneously dissociate or be redistributed to the endomem-Submitted July 29, 2013, and accepted for publication November 8, 2013.
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0006-3495/14/01/0093/13 $2.00brane system due to membrane fission processes such as
endocytosis. Thus, S-palmitoylated proteins enriched at
the PM will eventually equilibrate to a random distribution
on all membranes in the cell that is indistinguishable from
their nonpalmitoylated forms (1,7). However, widespread
thioesterase activity in the cell depalmitoylates these
proteins on endomembranes, thereby converting slowly
diffusing, randomly distributed (mislocalized) palmitoy-
lated proteins to their rapidly diffusing unpalmitoylated
forms, allowing them to get efficiently (re-)trapped and
concentrated at the Golgi apparatus by repalmitoylation
(1,4,7). It is therefore the palmitoylation trap at the Golgi
that maintains the out-of-equilibrium distribution of palmi-
toylated peripheral membrane proteins. The acylation cycle
has been shown to be a constitutive and general correction
mechanism that counters equilibration (mislocalization)
over all endomembranes and generates the dynamic PM/
Golgi localization of several palmitoylated peripheral mem-
brane proteins (1). Although additional nuances in spatial
localization can be conferred by additional modifications
or domains in these proteins, perturbation of the acylation
cycle typically results in disruption of the native localization
of palmitoylated peripheral membrane proteins. For
example, inhibition of the depalmitoylation activity restricts
these proteins to a randomized aspecific distribution over
endomembranes in their palmitoylated state (7). This pre-
vents enrichment on the Golgi, causing subsequent loss of
specific PM localization and suppression of oncogenic
signaling by palmitoylated Ras family proteins. This critical
depalmitoylation has been shown to be performed by the
thioesterases acyl protein thioesterase 1 (APT1) and its ho-
molog, APT2, in cells (7–10), but little is known about how
thioesterase activity is regulated to maintain the localizationhttp://dx.doi.org/10.1016/j.bpj.2013.11.024
94 Vartak et al.of palmitoylated substrates on the PM. APT activity must be
tightly regulated in the cell; too much activity will cause
depalmitoylated substrates to equilibrate to all endomem-
branes, whereas too little will cause the same randomized
distribution of palmitoylated substrates. Although alterna-
tive regulatory mechanisms based on inactivation of APTs
by dimerization (11) have been suggested, biochemical
labeling experiments have shown APT1/2 to be palmitoy-
lated (12). Recently, it was also reported that APT1/2 are
palmitoylated at Cys-2, and that APT1 is capable of depal-
mitoylating itself as well as APT2 (13). This raises the pos-
sibility that an acylation cycle on APTs could also affect
thioesterase activity within the cell. We therefore investi-
gated the dynamic mechanisms that regulate thioesterase
activity in cellular space, and what role these mechanisms
play in maintaining palmitoylated peripheral membrane
proteins in specific membrane compartments.MATERIALS AND METHODS
For a description of the molecular and cell biology procedures used in this
work, see Supporting Material.Confocal imaging
Confocal laser scanning microscopy was performed on a Leica TCS SP5
DMI6000 equipped with an HCX PL APO 63 1.4-.6 NA Blau CS objec-
tive and an environment-control chamber maintained at 37C and 5% CO2.
mCerulean, mCitrine, and mCherry fluorescence was excited using
458 nm and 514 nm argon laser lines and a 561 nmHeNe laser, respectively.
Detection of fluorescence emission was restricted with an Acousto-Optical
Beam Splitter (AOBS) as follows: mCerulean, 468–504 nm; mCitrine, 524–
551 nm; and mCherry, 571–650 nm. Scanning was performed in line-by-
line sequential mode with 2 line averaging. Confocality was controlled
by limiting the pinhole size between 1.0 and 1.5 Airy units.Fluorescence recovery after photobleaching
imaging and quantification
Fluorescence recovery after photobleaching (FRAP) experiments were
carried out at 37C on a Leica SP5 confocal microscope with settings
similar to those described above, typically with a 63 oil immersion objec-
tive. Cells were allowed to equilibrate in the environment-control chamber
on the microscope. A custom routine was set up that included the three steps
of FRAP analysis: 1), prebleach imaging; 2), bleaching; and 3), postbleach
imaging.
For a detailed description of the FRAP experiments and analysis, see
Supporting Material.Fo¨rster resonance energy transfer/fluorescence-
lifetime imaging microscopy-based enzyme-
substrate imaging of APT activity
Fluorescence lifetime imaging microscopy (FLIM) experiments were car-
ried out at 37C on a Leica SP5 or Olympus FV1000 confocal microscope
equipped with Picoquant FLIM modules (LSM Upgrade Kit/SMDModule;
Picoquant). On the Leica SP5, mCitrine fluorescence was excited at 514 nm
with a pulsed supercontinuum laser with a repetition rate of 79.2 MHz.
Fluorescence signal was collected as described above. On the OlympusBiophysical Journal 106(1) 93–105FV1000, a pulsed 470 nm diode laser (LDH 470; Picoquant) with a repeti-
tion rate of 40 MHz was used. Fluorescence signal was collected through an
oil immersion objective (60/1.35 UPlanSApo (Olympus) or HCX PL
APO 63x 1.4-.6 NA Blau CS (Leica)) and spectrally filtered using a nar-
row-band emission filter (HQ 525/15; Chroma).
Photons from the mCitrine channel were detected using avalanche
photodiodes (APDs) and a time-correlated single-photon counting
(TCSPC) module (PicoHarp 300; Picoquant).
To obtain the molar fraction of enzyme substrate over total enzyme (ES/
ET) of APT-mCitrine (Fo¨rster resonance energy transfer (FRET) donor) in
complex with the substrate Ga (1-11)-mCherry or APT1/2-mCherry (FRET
acceptors) (14), FLIM data sets were analyzed as previously described (15).
To estimate the extent of ES complexes on membranes, the fraction of
pixels per cell with an ES/ET above a certain threshold was computed.
This threshold was determined as the mean þ 2 standard deviations
(SDs) of ES/ET values in the APT substrate-free nucleus of the cell.
For a detailed description of the FLIM experiments and analysis, see
Supporting Material.Metabolic labeling, click chemistry, and western
blotting to detect palmitoylation
To detect palmitoylation of APT proteins, we performed metabolic labeling
with 15-hexadecynoic acid (15-HDYA) in MDCK cells expressing His-
tagged APT wild-type (WT) or APTC2S. 15-HDYA is a palmitate analog
with an u-alkyne group. The alkyne group can be utilized for Huisgen
azide-alkyne 1,3-dipolar cycloaddition with biotin azide, allowing covalent
labeling of palmitoylated proteins with biotin.
For a more detailed description, see Supporting Material.RESULTS
APT palmitoylation generates a cytoplasmic and
Golgi pool of thioesterase activity
Ectopically expressed, fluorescently tagged APT1-mCitrine
and APT2-mCitrine showed a characteristic diffuse cyto-
plasmic localization (16). In addition to this large cyto-
plasmic fraction, both proteins also exhibited enrichment
on the Golgi apparatus, reminiscent of the localization of
their palmitoylated substrates (Fig. 1, A–C). This distribu-
tion indicates that APT1/2 are palmitoylated and may be
substrates of their own depalmitoylating activity. Bioinfor-
matics analysis with CSS-PALM 3.0 (17) showed that the
conserved Cys residue at position 2 (Fig. S1) of both pro-
teins has a high probability of being palmitoylated. In line
with these observations, APTs were recently reported to
be palmitoylated at the Cys residue at position 2 (13). To
determine the connection between this conserved Cys resi-
due and localization of APTs in the cell, we compared the
localization of WT APT1/2-mCitrine and Cys2-to-Ser
point-mutated APT1/2-C2S-mCitrine (Fig. 1, A–C). WT
APTs localized to the Golgi as well as the cytosol, whereas
the C2S mutation abolished Golgi enrichment. APTs do not
possess any irreversible lipid modification such as prenyla-
tion or myristoylation, and therefore unpalmitoylated APTs
are entirely cytosolic. Localization of WT APTs on the
Golgi apparatus was also lost when cells were treated with
2-bromopalmitate, a general inhibitor of palmitoylation
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FIGURE 1 Localization of APT1-mCitrine and APT2-mCitrine in live cells shows a cytosolic pool and significant Golgi enrichment. GalT-mCerulean
fluorescence marks the Golgi apparatus. Ga (1-11)-mCherry is an N-terminal 11-amino-acid fragment of Gai1, a palmitoylated substrate of APTs. (A) Local-
ization of WTAPT1-mCitrine (WT, top row), Cys2-to-Ser mutant APT1C2S-mCitrine (C2S, second row), APT1-mCitrine under inhibition of palmitoylation
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96 Vartak et al.and palmitate synthesis (18), again leaving the APTs cyto-
solic. In contrast to their palmitoylated substrates, no enrich-
ment of APTs on the PM was observed. However, specific
inhibition of cellular thioesterase activity using Palmostatin
B results in stabilization of APT palmitoylation and has
been reported to result in a subsequent localization of
APTs to the PM (13). This temporary and nonphysiological
localization can arise from the stabilized palmitoylated state
of APT, which interacts long enough with membranes to be
transported from the Golgi via vesicular transport (Fig. 1 C;
see also Fig. 3). However, prolonged thioesterase inhibition
by Palmostatin B leads to stabilization of APT palmitoyla-
tion, resulting in an entropic equilibration to an aspecific
redistribution of APTs to all cellular membranes, as is char-
acteristic for palmitoylated proteins when the acylation
cycle is interrupted (7). Some residual enrichment of
APTs that remains at the Golgi apparatus may be attributed
to residual cycling due to incomplete inhibition of thio-
esterase activity or weak interactions with Golgi-resident
proteins. Using metabolic labeling with 15-hexadecynoic
acid followed by click chemistry (19) to detect palmitoyla-
tion (Fig. 1 D), we confirmed that APTs, but not APTC2S
mutants, are indeed palmitoylated. We therefore conclude
that APT1/2 are palmitoylated at the Cys residue at position
2, and that this is the primary cause of APT enrichment on
the Golgi. Changes in its localization upon thioesterase in-
hibitor or palmitoylation inhibitor treatment suggest that
this palmitoylation is dynamic and APTs undergo an acyla-
tion cycle that is responsible for the enrichment of these pro-
teins on the Golgi apparatus.Golgi and cytoplasmic APT pools interconvert
rapidly due to labile palmitoylation
To ascertain the reversibility of APT palmitoylation, we per-
formed FRAP studies on APT1/2-mCitrine on the Golgi
apparatus. APT1/2-mCitrine fluorescence intensity recov-
ered rapidly on the Golgi apparatus after photobleaching
(Fig. 2, A–E). APT localization to the Golgi is therefore
dynamic, suggesting reversible S-palmitoylation as its
cause. The fluorescence recovery times did not show any
dependence on the total fluorescence intensity of ectopically
expressed APT1-mCitrine or coexpressed APT1-mCherry,
indicating that APT acylation dynamics on the Golgi appa-
ratus are robust with respect to varying expression levels of
total thioesterase activity (Fig. 2, D). However, since the
APTs themselves are thioesterases, ectopic expression of
WTAPTs undoubtedly alters the gross thioesterase activity
in the cell, and as such, our measurements may not reflect
the fraction of palmitoylated protein as determined by the
endogenous thioesterase activity. Therefore, catalytically
inactive mutants APT1(S119A) and APT2(S122A) were
expressed to serve as tracers for APT1 palmitoylation and
localization without altering thioesterase activity in the cell.Biophysical Journal 106(1) 93–105The localization of APT1(S119A) and APT2(S122A) was
similar to that of WT APTs (Fig. 1, A and B). Therefore,
changes in gross cellular thioesterase activity do not have
a significant effect on APT localization. However, the
catalytically inactive APTs showed significantly reduced
fluorescence recovery times on the Golgi apparatus as
compared to their WT counterparts (Fig. 2, E and F).
Fluorescence recovery times on the Golgi are determined
by the balance between palmitoylation and depalmitoyla-
tion activities that would be slowed by any autodepalmitoy-
lating activity of Golgi-localized APTs. The enhanced
thioesterase activity upon ectopic expression of WT
APT1/2 thus leads to an apparent retardation of fluorescence
recovery after photobleaching, and the faster recovery of
catalytically inactive mutants indicates that APT1/2 autode-
palmitoylate on the Golgi.
Consistent with these results, inhibition of APT catalytic
activity by Palmostatin B blocks fluorescence recovery of
APT1/2-mCitrine after photobleaching on the Golgi (Fig. 2,
B andC). The redistribution of APTs to endomembranes after
inhibition of thioesterase activity occurs over an hour (7),
whereas the data presented here show that palmitate turnover
on APTs is on the order of seconds in the presence of thio-
esterase activity. Therefore, the average residence time of
APTs on membranes is too short to generate any substantial
PM or endomembrane enrichment, in agreement with locali-
zation studies in which no such enrichment was detected
in confocal micrographs of ectopically expressed APTs
(Fig. 1). The nonphysiological PM localization can be tran-
siently inducedby inhibition of thioesterase activity usingPal-
mostatin B to stabilize the palmitoylated state of APTs on
membranes long enough for them to be transported from the
Golgi via vesicular transport to the PM (Fig. 3,A andB). After
prolonged thioesterase inhibition, the palmitoylated APTs
eventually equilibrate to an aspecificdistribution to all cellular
membranes (Fig. 1,A andB), as is characteristic for palmitoy-
lated proteins when the acylation cycle is interrupted (7).
The steady-state partitioning in the Golgi and cytosol of
APTs is similar and seemingly unaffected by the levels
of total thioesterase activity in the cell. Therefore, the rate
of recruitment and rate of loss of APTs from the Golgi
compartment must be maintained in proportion. The nega-
tive feedback on thioesterase activity due to autodepalmi-
toylation of APTs on the Golgi could be a mechanism to
maintain such proportionality. In this scenario, the apparent
rate of fluorescence recovery for a given APT species would
appear to be independent of the total thioesterase activity in
the cell but dependent on the Golgi localized thioesterase
activity, consistent with our observations.APTs autodepalmitoylate on the Golgi,
generating a homeostatic negative feedback
To determine whether a negative feedback due to APT
autodepalmitoylation on the Golgi occurs, we directly
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98 Vartak et al.investigated the presence of ES complexes between APTs in
live cells. FLIM (19) was performed to image the interaction
between mCitrine- and mCherry-tagged APTs quantita-
tively. The application of FLIM to quantify the fraction of
ES complexes that undergo FRET is referred to as ES imag-
ing (14).
ES imaging was performed using combinations of APT1/
2-mCitrine donor fusion constructs with APT1/2-mCherry
acceptor fusion constructs. Interaction between APT1-
APT1, APT2-APT2, and APT1-APT2 was detected on the
Golgi apparatus, with no detectable interaction in the cyto-
plasm at steady state (Fig. 4). This high interacting fraction
at the Golgi is maintained by the continuous replenishment
of palmitoylated APTs at the Golgi due to the local palmi-
toyltransferase activity (1,20,21), and is lost upon inhibition
of APTs with Palmostatin B, which reacts with the catalytic
serine in its active site (7) (Fig. 4 A, second column, and B).
Therefore, the interaction occurs at the active site of at least
one of the APTs in the complex and confirms the formation
of ES complexes. Correspondingly, the lack of any signifi-
cant interaction in the cytoplasm confirms that cytoplasmic
soluble APTs are unpalmitoylated and represent the depal-
mitoylated product of the thioesterase activity. We also
demonstrate the formation of equivalent homotypic and het-
erotypic ES complexes between APT1/2, showing that both
APTs can depalmitoylate themselves or their paralog with
similar efficiency.
To rule out the possibility of aspecific FRET between
APTs, we generated spatial maps of the ratio of (ES/ET)
over (acceptor/donor) intensity. This ratio is equivalent torecovery for APTs and their catalytically inactive mutants with respect to inten
fluorescence recovery on Golgi for APTs and their catalytically inactive mutants.
is the coefficient of determination indicating goodness-of-fit. (F) Rigorous error
Golgi. Error bars represent SD of the goodness-of-fit (r2) for multiple cells.
Biophysical Journal 106(1) 93–105the ES/acceptor ratio and indicates the dependence of the
FRET signal on acceptor concentrations. The ES FRET
signal did not show any dependence on acceptor intensity,
indicating that the acceptor is present at saturating concen-
trations with respect to the APT-binding sites. Indeed, upon
treatment with Palmostatin B, the ES/acceptor ratio in the
Golgi apparatus was lower than that in the cytoplasm, in
spite of the high acceptor concentrations present in the
Golgi apparatus (Fig. 4 A, fourth row, second column).
Additionally, a pixelwise correlation analysis of the FRET
signal with respect to the acceptor intensity gave an average
Pearson’s correlation of 0.09 for all conditions in the Golgi,
and 0.0 in the PM (Fig. S2 A). The lack of a significant
correlation between the ES/ET and acceptor/donor ratio
affirms the conclusion that the FRET signal is specific and
not a result of acceptor-concentration-dependent bystander
FRET (22).Soluble depalmitoylated APTs depalmitoylate
mislocalized substrates on endomembranes
To test whether the APTs can access palmitoylated sub-
strates on endomembranes, we performed ES imaging (14)
to directly quantify the interaction between mCitrine-tagged
APT enzymes and an mCherry-tagged palmitoylated sub-
strate in live cells. For this purpose, we coexpressed
APT1/2-mCitrine with Ga (1-11)-mCherry, an 11-amino
acid N-terminal palmitoylated fragment of a substrate of
APT1, and quantified the spatial distribution and extent of
the ES interaction. Under normal conditions, APT1 andsity of APT1/2-mCitrine or coexpressed APT1-mCherry. (E) Half times of
Error bars are SDs as derived from searching error space in the global fit; r2
analysis of fits spanning a range of t1/2 (s) values for APT recovery on the
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100 Vartak et al.the substrate were found to interact extensively on the Golgi
apparatus, detected as a high fraction of APT1/2-mCitrine
exhibiting FRET with the substrate (Fig. 5, A and B). The
fraction of APT that interacted with substrate was reduced
after the cells were incubated with Palmostatin B, which in-
hibits APTactivity by reacting with the catalytic serine in its
active site. This confirms that the FLIM signal indeed re-
ports on the binding of the substrate in the active site of
APTs. The high molar fraction of APT-substrate complex
that is detected on the Golgi is likely due to the continuous
regeneration of palmitoylated substrate from depalmitoy-
lated product by the local palmitoyltransferase activity. A
substantial fraction of the soluble APTs that interacts with
the membrane-bound substrate could also be measured on
the PM due to the local enrichment of the palmitoylated
Ga (1-11)-mCherry that is transported to the PM by the
secretory pathway (Fig. 5 A). By contrast, the APT-substrate
complex could not be detected on other endomembranes in
the cytoplasm. This is likely due to endomembranes being
virtually devoid of palmitoylated substrate due to depalmi-
toylation activity in the acylation cycle.
We confirmed the specificity of the FRET signal for
the APT1-mCitrine (donor) and Ga (1-11)-mCherry
(acceptor) pair by generating spatial maps of the ES/
acceptor ratio on the Golgi (Fig. 5 B, left) and PM, and
performing a correlation analysis as described above. PM
and Golgi segmentation of the spatial maps showed that
variance of the ES FRET signal does not depend on acceptor
intensity. Thus, wherever the acceptor is localized, it is pre-
sent at saturating concentrations with respect to the APT-
binding sites. This was corroborated by the near absence
of Pearson’s correlation between (ES/ET) and (acceptor/
donor) intensity (r ¼ 0.04 on Golgi and 0.07 on PM)
throughout the Palmostatin B incubation (Fig. S2 B).
FLIM measurements of the FRET between APT1-mCitrine
and the unpalmitoylated Golgi-membrane-resident protein
GalT-mCherry or the unpalmitoylated PM-resident protein
KRas-mCherry (Fig. 5 C) showed an insignificant fraction
a of APT1-mCitrine exhibiting FRET (a ¼ 0.02 5 0.03),
over a 3-fold variation of acceptor intensity, confirming
the absence of aspecific bystander FRET effects (22) in
our experiments.
To show that soluble APT activity acts on palmitoylated
substrates on endomembranes, the level of substrates on
endomembranes must be increased by interfering with the
acylation cycle. Ectopically expressed, palmitoylation-defi-
cient but catalytically active APT-C2S mutants do not
exhibit Golgi localization due to a lack of palmitoylation.
These types of mutants represent the cytoplasmic pool of
APTs that show a similar level of interaction with substrates
on the Golgi and PM as WTAPTs at steady state (Fig. 6 A,
first column, B, and C). To increase the level of substrates on
endomembranes, we incubated cells with Palmostatin B to
inhibit APT activity, which leads to a redistribution of
palmitoylated substrates to endomembranes. Under theseBiophysical Journal 106(1) 93–105conditions, the palmitoylation-deficient APT-C2S remains
cytoplasmic but is inactive (Fig. 6 A, second column, B,
and C). Removal of Palmostatin B from the cellular medium
leads to a slow reactivation of the enzyme by hydrolysis of
the Palmostatin B-APT-adduct (7), which precedes rein-
statement of the PM-Golgi localization of the substrate. A
substantial interaction of cytosolic, reactivated APTs with
the delocalized substrate can be observed in this transient
period (Fig. 6 A, third column, B, and C), which shows
that depalmitoylated, cytoplasmic APTs can act on mislo-
calized substrates on endomembranes. This interaction
eventually becomes undetectable as the reactivated depal-
mitoylation activity clears palmitoylated substrate from en-
domembranes and restores the steady-state substrate
localization on the Golgi and PM (Fig. 6, B and C).
To further substantiate that cytoplasmic APTs indeed
access their substrates on endomembranes, we studied the
stable interaction of catalytically impaired, palmitoylation-
deficient APT1-C2S,S119A-mCitrine with mislocalized
palmitoylated substrates. Palmostatin B inhibits thioesterase
activity by forming a stable covalent adduct with the
catalytic serine residue in the active site of APT1/2, which
leads to the redistribution of palmitoylated substrates on
all membranes. The interaction of cytoplasmic APTs with
mislocalized substrates can therefore be demonstrated
with a catalytic serine-lacking mutant that cannot react
with Palmostatin B but still forms stable, albeit un-
productive, ES complexes (7,11). In untreated cells, the
level of ES complexes with catalytically impaired
APT1C2S,S119A-mCitrine was much lower than that for
WT APT1/2-mCitrine (Fig. 6 A, fourth column, and C).
The overall lower level of catalytically impaired ES
complexes that was detected under these conditions is
probably due to competitive binding of endogenous active
APTs to the Ga (1-11)-mCherry substrate. However, upon
inhibition of endogenous APT activity by Palmostatin B,
cytosolic catalytically impaired APTs strongly interacted
with the mislocalized palmitoylated Ga (1-11)-mCherry
proteins on endomembranes (Fig. 6 A, fifth column, and
C). Inhibiting palmitoylation of the substrate with 2-bromo-
palmitate abolished this interaction, confirming that APTs
interact with only palmitoylated Ga (1-11)-mCherry pro-
teins (Fig. 6 A, sixth column, and C). These experiments
show that depalmitoylated, soluble APTs can readily access
palmitoylated substrates bound to membranes, and that
ubiquitous depalmitoylation of substrates by APTs occurs
on all membranes.DISCUSSION
APT1/2 have been reported to be cytosolic enzymes based
on the presence of APT1 in cytosolic fractions of yeast cells
(8). Fractionation and immunohistochemical studies sug-
gested that hemagglutinin (HA)-tagged mammalian APT1/
2 are cytosolic and palmitoylated, and at least APT1 is
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102 Vartak et al.capable of autodepalmitoylation (13). In particular, Kong
et al. (13) reported that palmitoylation allows APTs to be
enriched on the PM in a canonical acylation cycle, and
thus enhances their reactivity toward their PM-bound sub-
strates. However, this view does not take into account the
spatial dynamics and stability of APT palmitoylation.
Indeed, the enrichment of APT thioesterase activity on the
PM is antagonistic to the enrichment of its palmitoylated
substrates, and would impede the PM-localized functions
of palmitoylated proteins of the Ras and Src family. We pro-
vide evidence for an alternative model wherein APTs do not
localize to the PM. Rather, soluble unpalmitoylated APTs
can depalmitoylate their substrates on all membranes in
the cell such that they can be repalmitoylated and trapped
on the Golgi apparatus. This model, where cytosolic APTs
counter equilibration of their substrates over all membranes,
is consistent with the known function of the acylation cycle
to enrich palmitoylated proteins on the PM.
The data presented here show that in mammalian cells, a
significant fraction of APTs are enriched on the Golgi appa-
ratus due to dynamic S-palmitoylation, and that APTs can
autodepalmitoylate in trans. In contrast to other proteins
that undergo the acylation cycle, APTs possess only a single
reversible lipidation site and lack irreversible lipidations
such as S-prenylation or N-myristoylation. Further, palmi-
toylation of APTs on the Golgi counteracts itself as it
concomitantly recruits and enriches the opposing thio-
esterase activity. The membrane attachment of APTs is
therefore labile, and far too short-lived for APTs to be trans-
ported to the PM via the secretory pathway. Thus, the auto-
catalytic acylation cycle of APTs maintains its steady-state
distribution between the cytosol and Golgi apparatus, in
contrast to its substrates that are partitioned between the
Golgi and the PM.
Palmitoylation of APTs could enhance their reactivity
toward their membrane-bound substrates. Yet, palmitoyla-
tion localizes the depalmitoylating activity of APTs to the
Golgi apparatus, a compartment where the opposing palmi-
toylation activity occurs. The absence of APTs on endo-
membranes where in fact depalmitoylation of mislocalized
proteins should occur is a result of their labile palmitoyla-
tion. Here, we resolve this conundrum by demonstrating
ES complexes of unpalmitoylated cytosolic APTs with
membrane-bound palmitoylated substrates on endomem-
branes. We thus demonstrate the role of the depalmitoylated,
cytoplasmic pool of APTs in the depalmitoylating activity(indicated in gray). (B) Magnified view of Golgi in A shows a spatial map of (ES/
(Acceptor/Donor). Graph shows quantification of average ES/ETon the Golgi ver
(C) Representative example of cells showing interaction of APT1-mCitrine with t
nonpalmitoylated PM-resident protein mCherry-KRas (bottom row). Columns sh
mCherry-KRas (acceptor) intensity, and average fraction (a) of APT1-mCitrine m
the average fraction of molecules exhibiting FRET (a, mean þ SD) for cells (n
(black) acceptors.
Biophysical Journal 106(1) 93–105that corrects mislocalization of palmitoylated proteins on
endomembranes in the acylation cycle.
What, then, is the role of palmitoylation and the Golgi-
localized pool of APTs? Several lines of evidence presented
in this work show that dynamic S-palmitoylation creates a
negative feedback of APT activity on the Golgi. This cou-
ples the rate of palmitoylation to the rate of depalmitoyla-
tion on Golgi membranes, thereby establishing a balance
that controls the steady-state amounts of palmitoylated sub-
strates on the Golgi. This renders the partitioning of
substrates in the acylation cycle robust with respect to vari-
ations in cellular geometry (23), vesicular transport (24,25),
organelle structure, palmitate metabolism, and other dy-
namic factors. Although the specificity and regulation of
protein palmitoyltransferases are currently poorly under-
stood, we previously reported that in mammalian cells, the
partitioning of peripheral-membrane proteins remains rela-
tively unaffected by an RNAi-mediated reduction in the
palmitoylation activity of specific DHHC proteins (1). In
this case, the negative feedback loop created by the autode-
palmitoylating APT activity would compensate for the
decreased palmitoylation by reducing the opposing local
thioesterase activity. In concert with other recently
described mechanisms that regulate access of APTs to their
substrates (26), such a negative feedback would also render
the acylation cycle resilient against perturbations of APT
activity, thus maintaining substrate partitioning over mem-
brane compartments (7,26). Simulation of APT palmitoyla-
tion dynamics on the Golgi supports this model, wherein the
negative feedback loop imparts robustness to the acylation
cycle of its substrates (Fig. 7). In this two-compartment
model, substrate partitioning is defined as the ratio of sub-
strate localized to the Golgi compartment to substrate local-
ized in the cytosol compartment (see ‘‘Simulation of APT
dynamics on the Golgi apparatus’’ in the Supporting Mate-
rial). An instantaneous increase of the amount of substrate
localized to the Golgi results in a rapid increase of the sub-
strate partitioning, which recovers to the original steady
state due to the negative feedback mediated by APT thio-
esterase activity on the Golgi. This recovery is absent
when APTs cannot be palmitoylated and therefore are not
localized to the Golgi. The simulation thus conceptually
shows that the negative feedback in the system maintains
a constant amount of APT on the Golgi apparatus at steady
state, and ensures that variations in substrate concentrations
or thioesterase concentrations do not alter substrate
partitioning over cellular membranes. This implies thatET) and ES/Acceptor. ES/Acceptor is equivalent to the ratio of (ES/ET) over
sus Palmostatin B incubation time (min). Error bars denote SEM for (n¼ 5).
he nonpalmitoylated Golgi-resident protein GalT-mCherry (top row) and the
ow (from left to right) APT1-mCitrine (donor) intensity, GalT-mCherry or
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Autodepalmitoylation of APTs 103thioesterase inhibition must be persistent and nearly com-
plete to affect the activities of palmitoylated substrate pro-
teins, such as oncogenic HRas, in a therapeutic setting.
Indeed, previous studies have required extended incubation
at high thioesterase inhibitor concentrations (7) or chronicdownregulation (27–29) to observe effects on cell physi-
ology. On the other hand, palmitoyltransferases have been
reported to have overlapping specificity, and such a negative
feedback at the level of the thioesterase activity on the Golgi
would allow the system to generate a variety of partitioningBiophysical Journal 106(1) 93–105
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FIGURE 7 Substrate partitioning is robust when APTs are palmitoylated.
Representative simulation of substrate dynamics between the Golgi and the
cytosol with translocation between compartments coupled to palmitoyla-
tion state. Substrate partitioning is defined as the ratio of substrate con-
centration on the Golgi versus that in the cytosol. When APTs are
palmitoylated, substrate partitioning recovers to steady state from a peri-
odic and cumulative increase of substrate concentration on the Golgi (red
arrows). This homeostatic behavior is completely lost when APTs are not
palmitoylated. Initial conditions for this particular simulation run: SCyt ¼
5 mM, SGolgi¼ 0 mM, APTCyt¼ 5 mM, APTGolgi¼ 0 mM, and (S-palmitoyl-
transferase activity) PAT ¼ 10 mM; parameters: kcatPAT ¼ 1 s1, kcatAPT ¼
1 s1, kM
PAT ¼ 1 mM, and kMAPT ¼ 0.1 mM.
104 Vartak et al.modes for different proteins depending on the relative
affinities of these proteins to palmitoyltransferases and
APTs, and the strength of the negative feedback. The auto-
depalmitoylating activity of APTs therefore adds a nested
reaction cycle as a layer of regulation to the acylation cycle
of APT substrates in maintaining specific spatial partition-
ing of palmitoylated peripheral-membrane proteins over
cellular membranes.SUPPORTING MATERIAL
Two figures, References (30–41) and supplemental information are avail-
able at http://www.biophysj.org/biophysj/supplemental/S0006-3495(13)
01258-7.
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